The role of G protein-coupled receptors in mast cell activation by antimicrobial peptides: Is there a connection

Immunology and Cell Biology

Volumn 88, Issue 6, 2010, Pages 632-640

  Pundir, Priyanka ^a,b   Kulka, Marianna ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

antimicrobial peptides; G protein coupled receptors; inflammation; innate immunity; mast cell; neuropeptides

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CALCITONIN GENE RELATED PEPTIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ICOSANOID; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; POLYPEPTIDE ANTIBIOTIC AGENT; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIBACTERIAL ACTIVITY; CELL ACTIVATION; CELL INTERACTION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOLYSIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MAST CELLS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 77955659961     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.27     Document Type: Review

References (121)

1. Salzet M. Antimicrobial peptides are signaling molecules. Trends Immunol 2002; 23: 283-284.
2. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006; 117: 1214-1225; quiz 26.
3. Siraganian RP. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 2003; 15: 639-646.
4. Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y. G protein activation: a receptorindependent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 1990; 11: 358-362.
5. Hamm HE, Gilchrist A. Heterotrimeric G proteins. Curr Opin Cell Biol 1996; 8: 189-196.
6. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 1997; 11: 346-354.
7. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-150.
8. Hancock RE. Peptide antibiotics. Lancet 1997; 349: 418-422.
9. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005; 3: 238-250.
10. Brotz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 1998; 42: 154-160.
11. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 1989; 84: 553-561.
12. Otvos Jr L, Insug O, Rogers ME, Consolvo PJ, Condie BA, Lovas S et al. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 2000; 39: 14150-14159.
13. Porter EM, Liu L, Oren A, Anton PA, Ganz T. Localization of human intestinal defensin in Paneth cell granules. Infect Immun 1997; 65: 2389-2395.
14. Jones DE, Bevins CL. Defensin- mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett 1993; 315: 187-192.
15. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-335.
16. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998; 95: 14961-14966.
17. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.
18. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH. Expression of beta-defensin and mRNA by human monocytes, macrophages and dendritic cells. Immunology 2002; 106: 517-525.
19. Becker MN, Diamond G, Verghese MW, Randell SH. CD14-dependent lipopolysaccharide- induced beta-defensin- expression in human tracheobronchial epithelium. J Biol Chem 2000; 275: 29731-29736.
20. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK et al. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999; 67: 2740-2745.
21. Joly S, Organ CC, Johnson GK, McCray Jr PB, Guthmiller JM. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol 2005; 42: 1073-1084.
22. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001; 15: 1819-1821.
23. Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 2006; 1758: 1408-1425.
24. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L et al. The human antimicrobial and chemotactic peptides LL- and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-3093.
25. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997; 90: 2796-2803.
26. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP- is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95: 9541-9546.
27. Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H et al. The expression of the gene coding for the antibacterial peptide LL- is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272: 15258-15263.
28. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C et al. NF-kappaB- and AP-1-mediated induction of human beta defensin- in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 2004; 72: 5750-5758.
29. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006; 18: 24-30.
30. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K et al. Inducible and constitutive beta-defensins are differentially expressed in Crohns disease and ulcerative colitis. Inflamm Bowel Dis 2003; 9: 215-223.
31. Weiner DJ, Bucki R, Janmey PA. The antimicrobial activity of the cathelicidin LL is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 2003; 28: 738-745.
32. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
33. Schroder NW, Maurer M. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007; 62: 579-590.
34. Sumikawa Y, Asada H, Hoshino K, Azukizawa H, Katayama I, Akira S et al. Induction of beta-defensin in keratinocytes stimulated by bacterial lipopeptides through tolllike receptor 2. Microbes Infect 2006; 8: 1513-1521.
35. Funderburg N, Lederman MM, Feng Z, Drage MG, Jadlowsky J, Harding CV et al. Human -defensin- activates professional antigen-presenting cells via Toll-like receptors and 2. Proc Natl Acad Sci USA 2007; 104: 18631-18635.
36. Yoshioka M, Fukuishi N, Kubo Y, Yamanobe H, Ohsaki K, Kawasoe Y et al. Human cathelicidin CAP18/LL- changes mast cell function toward innate immunity. Biol Pharm Bull 2008; 31: 212-216.
37. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000; 173: 27-38.
38. Kaslow HR, Burns DL. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J 1992; 6: 2684-2690.
39. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192: 1069-1074.
40. ONeil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T et al. Expression and regulation of the human beta-defensins hBD- and hBD- in intestinal epithelium. J Immunol 1999; 163: 6718-6724.
41. Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A et al. Elevated human beta-defensin- levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 404-410.
42. Bischoff SC, Kramer S. Human mast cells, bacteria, and intestinal immunity. Immunol Rev 2007; 217: 329-337.
43. Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985; 162: 1025-1043.
44. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-1079.
45. Metz M, Maurer M. Mast cells-key effector cells in immune responses. Trends Immunol 2007; 28: 234-241.
46. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003; 170: 2274-2278.
47. von Kockritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, Rohde M et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 2008; 111: 3070-3080.
48. Vig M, Kinet JP. Calcium signaling in immune cells. Nat Immunol 2009; 10: 21-27.
49. Puri N, Kruhlak MJ, Whiteheart SW, Roche PA. Mast cell degranulation requires N-ethylmaleimide-sensitive factor-mediated SNARE disassembly. J Immunol 2003; 171: 5345-5352.
50. Fujishima H, Sanchez Mejia RO, Bingham 3rd CO, Lam BK, Sapirstein A, Bonventre JV et al. Cytosolic phospholipase A is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 1999; 96: 4803-4807.
51. Clapham DE, Neer EJ. G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 1997; 37: 167-203.
52. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor- enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986; 136: 4538-4541. (Pubitemid 16090673)
53. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G et al. Interleukin induces interleukin 4-independent IgG and IgE synthesis and CD expression by human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-3734.
54. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R et al. IL- induces characteristic Th responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17: 7-17.
55. Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007; 217: 141-154.
56. Weller CL, Collington SJ, Brown JK, Miller HR, Al-Kashi A, Clark P et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005; 201: 1961-1971.
57. Habermann E. Bee and wasp venoms. Science 1972; 177: 314-322.
58. Nakajima T, Uzu S, Wakamatsu K, Saito K, Miyazawa T, Yasuhara T et al. Amphiphilic peptides in wasp venom. Biopolymers 1986; 25: S115-S121.
59. Hirai Y, Kuwada M, Yasuhara T, Yoshida H, Nakajima T. A new mast cell degranulating peptide homologous to mastoparan in the venom of Japanese hornet (Vespa xanthoptera). Chem Pharm Bull (Tokyo) 1979; 27: 1945-1946.
60. Ho CL, Hwang LL. Structure and biological activities of a new mastoparan isolated from the venom of the hornet Vespa basalis. Biochem J 1991; 274: 453-456.
61. Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R. Two families of antimicrobial peptides from wasp (Vespa magnifica) venom. Toxicon 2006; 47: 249-253.
62. Ziai MR, Russek S, Wang HC, Beer B, Blume AJ. Mast cell degranulating peptide: a multi-functional neurotoxin. J Pharm Pharmacol 1990; 42: 457-461.
63. Higashijima T, Burnier J, Ross EM. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem 1990; 265: 14176-14186.
64. Okano Y, Takagi H, Tohmatsu T, Nakashima S, Kuroda Y, Saito K et al. A wasp venom mastoparan-induced polyphosphoinositide breakdown in rat peritoneal mast cells. FEBS Lett 1985; 188: 363-366.
65. Argiolas A, Pisano JJ. Facilitation of phospholipase A activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem 1983; 258: 13697-13702.
66. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999; 163: 947-953.
67. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993; 155: 408-413.
68. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007; 179: 3958-3965.
69. Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/- and LL- on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 2001; 31: 1066-1075.
70. Chen X, Niyonsaba F, Ushio H, Hara M, Yokoi H, Matsumoto K et al. Antimicrobial peptides human beta-defensin (hBD)- and hBD- activate mast cells and increase skin vascular permeability. Eur J Immunol 2007; 37: 434-444.
71. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I. Epithelial cell-derived human beta-defensin- acts as a chemotaxin for mast cells through a pertussis toxinsensitive and phospholipase C-dependent pathway. Int Immunol 2002; 14: 421-426.
72. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H et al. A cathelicidin family of human antibacterial peptide LL- induces mast cell chemotaxis. Immunology 2002; 106: 20-26.
73. Chen X, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K et al. Human cathelicidin LL- increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p and ERK in mast cells. J Dermatol Sci 2006; 43: 63-66.
74. Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 2001; 69: 691-697.
75. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525-528.
76. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J. beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR is not involved. Eur J Immunol 2007; 37: 2474-2486.
77. El Karim IA, Linden GJ, Orr DF, Lundy FT. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol 2008; 200: 11-16.
78. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. Mast cell/ nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991; 143: S55-S58.
79. Maggi CA. The mammalian tachykinin receptors. Gen Pharmacol 1995; 26: 911-944.
80. Okayama Y, Ono Y, Nakazawa T, Church MK, Mori M. Human skin mast cells produce TNF-alpha by substance P. Int Arch Allergy Immunol 1998; 117: 48-51.
81. Lowman MA, Benyon RC, Church MK. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988; 95: 121-130.
82. Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther 1989; 250: 329-335.
83. Grundemar L, Hakanson R. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells. Br J Pharmacol 1991; 104: 776-778.
84. Erjavec F, Lembeck F, Florjanc-Irman T, Skofitsch G, Donnerer J, Saria A et al. Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol 1981; 317: 67-70.
85. Fewtrell CM, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 1982; 330: 393-411.
86. Devillier P, Drapeau G, Renoux M, Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. Eur J Pharmacol 1989; 168: 53-60.
87. Ogawa K, Nabe T, Yamamura H, Kohno S. Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats. Eur J Pharmacol 1999; 374: 285-291.
88. Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, Furuno M et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun 2006; 349: 1322-1328.
89. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123: 398-410.
90. Lorenz D, Wiesner B, Zipper J, Winkler A, Krause E, Beyermann M et al. Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J Gen Physiol 1998; 112: 577-591.
91. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Histamine H receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305: 1212-1221.
92. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002; 195: 583-592.
93. Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF et al. Expression of the type receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci USA 2003; 100: 11589-11593.
94. Weller CL, Collington SJ, Hartnell A, Conroy DM, Kaise T, Barker JE et al. Chemotactic action of prostaglandin E on mouse mast cells acting via the PGE receptor 3. Proc Natl Acad Sci USA 2007; 104: 11712-11717.
95. Selye H. Mast cells and necrosis. Science 1966; 152: 1371-1372.
96. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-4468.
97. Wingren U, Enerback L. Turnover of histamine in mucosal and connective tissue mast cells of the rat. Agents Actions 1984; 14: 358-360. (Pubitemid 14103291)
98. Verghese MW, Kneisler TB, Boucheron JA. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL cells. J Biol Chem 1996; 271: 15597-15601.
99. Burgers JA, Schweizer RC, Koenderman L, Bruijnzeel PL, Akkerman JW. Human platelets secrete chemotactic activity for eosinophils. Blood 1993; 81: 49-55.
100. Idzko M, Dichmann S, Panther E, Ferrari D, Herouy Y, Virchow Jr C et al. Functional characterization of P2Y and P2X receptors in human eosinophils. J Cell Physiol 2001; 188: 329-336.
101. Elssner A, Duncan M, Gavrilin M, Wewers MD. A novel P2X receptor activator, the human cathelicidin-derived peptide LL37, induces IL- beta processing and release. J Immunol 2004; 172: 4987-4994.
102. Khine AA, Del Sorbo L, Vaschetto R, Voglis S, Tullis E, Slutsky AS et al. Human neutrophil peptides induce interleukin- production through the P2Y signaling pathway. Blood 2006; 107: 2936-2942.
103. Feng C, Mery AG, Beller EM, Favot C, Boyce JA. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 2004; 173: 7539-7547.
104. Wareham K, Vial C, Wykes RC, Bradding P, Seward EP. Functional evidence for the expression of P2X1, P2X and P2X receptors in human lung mast cells. Br J Pharmacol 2009; 157: 1215-1224.
105. Hirai Y, Yasuhara T, Yoshida H, Nakajima T, Fujino M, Kitada C. A new mast cell degranulating peptide mastoparan in the venom of Vespula lewisii. Chem Pharm Bull (Tokyo) 1979; 27: 1942-1944.
106. Konno K, Hisada M, Naoki H, Itagaki Y, Kawai N, Miwa A et al. Structure and biological activities of eumenine mastoparan-AF (EMP-AF), a new mast cell degranulating peptide in the venom of the solitary wasp (Anterhynchium flavomarginatum micado). Toxicon 2000; 38: 1505-1515.
107. Mendes MA, de Souza BM, Palma MS. Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Toxicon 2005; 45: 101-106.
108. Souza BM, Mendes MA, Santos LD, Marques MR, Cesar LM, Almeida RN et al. Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista. Peptides 2005; 26: 2157-2164.
109. Chen W, Yang X, Zhai L, Lu Z, Liu J, Yu H. Antimicrobial peptides from the venoms of Vespa bicolor Fabricius. Peptides 2008; 29: 1887-1892.
110. Konno K, Rangel M, Oliveira JS, Dos Santos Cabrera MP, Fontana R, Hirata IY et al. Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus. Peptides 2007; 28: 2320-2327.
111. Konno K, Hisada M, Naoki H, Itagaki Y, Fontana R, Rangel M et al. Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus. Peptides 2006; 27: 2624-2631.
112. Konno K, Hisada M, Fontana R, Lorenzi CC, Naoki H, Itagaki Y et al. Anoplin, a novel antimicrobial peptide from the venom of the solitary wasp Anoplius samariensis. Biochim Biophys Acta 2001; 1550: 70-80.
113. Cerovsky V, Hovorka O, Cvacka J, Voburka Z, Bednarova L, Borovickova L et al. Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Chembiochem 2008; 9: 2815-2821.
114. Cerovsky V, Slaninova J, Fucik V, Hulacova H, Borovickova L, Jezek R et al. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Peptides 2008; 29: 992-1003.
115. Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y et al. Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Peptides 2006; 27: 3085-3091.
116. Graham C, Richter SC, McClean S, OKane E, Flatt PR, Shaw C. Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa. Peptides 2006; 27: 1313-1319.
117. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
118. Kowalska K, Carr DB, Lipkowski AW. Direct antimicrobial properties of substance P. Life Sci 2002; 71: 747-750.
119. Vouldoukis I, Shai Y, Nicolas P, Mor A. Broad spectrum antibiotic activity of the skin-PYY. FEBS Lett 1996; 380: 237-240.
120. Kuehn HS, Gilfillan AM. G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunol Lett 2007; 113: 59-69.
121. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006; 6: 218-230.